Clinical trials referral resource: Current clinical trials of epothilone B analog (BMS-247550)

被引：0
|
作者：
Colevas, AD [1 ]
West, PJ [1 ]
Cheson, BD [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1168 / +
页数：5
相关论文
共 50 条
  • [11] Phase I and pharmacology study of the epothilone B analog BMS-247550 in patients with advanced cancer.
    Spriggs, D
    Soignet, S
    Blenvenu, B
    Letrent, S
    Lebwohl, D
    Burris, H
    CLINICAL CANCER RESEARCH, 2000, 6 : 4580S - 4580S
  • [12] Phase I clinical trial of BMS-247550, a derivative of epothilone B, using accelerated titration 213 design
    Gadgeel, SM
    Wozniak, A
    Boinpally, RR
    Wiegand, R
    Heilbrun, LK
    Jain, V
    Parchment, R
    Colevas, D
    Cohen, MB
    LoRusso, PM
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6233 - 6239
  • [13] A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer
    Eng, C
    Kindler, HL
    Nattam, S
    Ansari, RH
    Kasza, K
    Wade-Oliver, K
    Vokes, EE
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 928 - 932
  • [14] A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma
    Huang, Hui
    Menefee, Michael
    Edgerly, Maureen
    Zhuang, Sen
    Kotz, Herb
    Poruchynsky, Marianne
    Huff, Lyn Mickley
    Bates, Susan
    Fojo, Tito
    CLINICAL CANCER RESEARCH, 2010, 16 (05) : 1634 - 1641
  • [15] Phase I trial of the epothilone B analog BMS-247550 (ixabepilone) in children with refractory solid tumors.
    Widemann, BC
    Fox, E
    Goodspeed, WJ
    Goodwin, A
    Cohen, M
    Fojo, T
    Colevas, AD
    Balis, FM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 807S - 807S
  • [16] Preclinical pharmacology of the epothilone B analog BMS-247550 - an epothilone analog possessing potent activity against paclitaxel sensitive and resistant human tumors.
    Lee, FYF
    Vite, GD
    Borzilleri, RM
    Arico, MA
    Clark, JL
    Fager, KL
    Kan, D
    Kennedy, KA
    Kim, ASH
    Smykla, RA
    Wen, ML
    Kramer, RA
    CLINICAL CANCER RESEARCH, 2000, 6 : 4580S - 4580S
  • [17] A phase 2 trial of BMS-247550 (ixabepilone), an epothilone B analog, given daily x 5 in breast cancer
    Low, JA
    Wedam, SB
    Brufsky, A
    Berman, A
    Croarkin, E
    Parks, R
    Steinberg, SM
    Mannan, N
    Fojo, T
    Swain, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 13S - 13S
  • [18] BMS-247550: A novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy
    Lee, FYF
    Borzilleri, R
    Fairchild, CR
    Kim, SH
    Long, BH
    Reventos-Suarez, C
    Vite, GD
    Rose, WC
    Kramer, RA
    CLINICAL CANCER RESEARCH, 2001, 7 (05) : 1429 - 1437
  • [19] Clinical Trials Referral Resource: Current Clinical Trials of R115777 (Zarnestra)
    Wright, JJ
    Zerivitz, K
    Gravell, AE
    Cheson, BD
    ONCOLOGY-NEW YORK, 2002, 16 (07): : 930 - +
  • [20] Clinical trials - Referral resource
    Murgo, AJ
    McBee, WL
    Cheson, BD
    ONCOLOGY-NEW YORK, 2000, 14 (02): : 206 - 206
12345